Chicory fibre, the root of digestive healthd3hip0cp28w2tg.cloudfront.net/uploads/2016-12/...Figure...
Transcript of Chicory fibre, the root of digestive healthd3hip0cp28w2tg.cloudfront.net/uploads/2016-12/...Figure...
Chicory fibre, the root of digestive health
Hélène Alexiou
Senior Manager Nutrition Communication
BENEO Institute
© 2016 BENEO
Natural solutions are top of mind to look after
digestive health
Q: What do you currently do to look after your digestive health?
n (UK) = 1099 | Filter: None
“High fibre diet;
plenty of fresh
fruit/vegetables.”
“Eat a balanced
diet with plenty
of fruit and
vegetables.”
“I eat
healthily
and
exercise
regularly.”
Q: Given the answer options below, what do you currently do to
look after your digestive health?
n (UK) = 1099 | Filter: None
Looking after digestive
health
TOP 5
% of
consumers
Drinking more water 58%
Eating fibre-rich foods 57%
Eating fruit 51%
Exercising 45%
Eating wholegrain
foods
41%
Source: BENEO’s digestive health research, 2015
© 2016 BENEO
Q: To what extent do you agree with the following motives for you to eat or drink digestive health products?
n (UK) = 1099 | Filter: None
Top 2 Drivers
5 – Completely agree 4 3 2 1 – Completely disagree
69%
66%
66%
66%
63%
62%
60%
58%
58%
53%
45%
27%
25%
24%
25%
24%
22%
22%
21%
22%
19%
16%
42%
41%
41%
40%
39%
40%
38%
37%
36%
34%
29%
28%
29%
30%
30%
31%
32%
34%
35%
35%
38%
42%
2%
3%
2%
3%
4%
4%
4%
4%
5%
7%
8%
2%
2%
3%
2%
2%
3%
3%
2%
3%
3%
5%
Is good for my overall health
Helps me keep my digestive system regular
Helps me feel healthy
Makes me feel better
Is good for my intestinal health
Helps me feel less bloated
Promotes good bacteria in the digestive system
Helps me improve my body’s natural defences
Relieves me from constipation
Contributes to a lowered risk of colorectal cancer
Can help me lose weight
Motives for eating or drinking digestive health
products
Source: BENEO’s digestive health research, 2015
© 2016 BENEO
The dietary fibre gap: Europe (females/males)
4 Literature search by BENEO Institute (2011); updated Aug 2016
Fra
nc
e
Be
lgiu
m
De
nm
ark
Sw
ed
en
Fin
lan
d
No
rwa
y
Th
e N
eth
erl
an
ds
Ge
rma
ny
Au
str
ia
Ita
ly
UK
Sp
ain
Po
rtu
ga
l
Ire
lan
d
-20
-15
-10
-5
0
5
Delta between dietary fibre intake and recommendation in g/day
females
males
© 2016 BENEO
Europe: prevalence of constipation
5
Spain: 4.1%1
France: 14 - 22.4%1
United
Kingdom:
7.7%1
Norway: 13.8%2
(Rome II criteria)
Germany:
14.9%1
Italy: 7.95%1
Greece: 13.8%3
Russia: 16.5%2
1: self-reported
2: according to Rome criteria II
3: according to Rome criteria III
Schmidt, de Gouveia Santos (2014) 41 (1): 70-76 Enck et al (2016) UEG J 4(3): 429-437
Wald et al (2008):Aliment Pharmacol Ther 28: 917-930
Lazebnik et al (2011) Ekep Clin Gastroenterol 3: 68-73
© 2016 BENEO
Inulin from chicory has a positive effect on bowel
function
6
Meta-analysis of 5 intervention studies (N=252):
• Showing significant effects of inulin on bowel motor function, including:
stool frequency
stool consistency
transit time
Supportive for a beneficial effect of inulin on bowel function!
Collado Yurrita et al. Nutr Hosp. 2014 Aug 1;30(2):244-52.
© 2016 BENEO
Chicory root fibres:
Inulin & Oligofructose
Chicory roots
(15-17% inulin)
© 2016 BENEO
Fermentation in the large intestine
Prebiotic fermentation
Increase in bacterial
metabolites
Increase in break down
products of chicory root
f iber fermentation:
Short chain fatty acids
(SCFA*)
Increase in bulk
Bacteria
Bacteria
Non-absorbed nutrients
from small intestine
Inulin/
Oligo-
fructose
SCFA
H2
CO2
Partial re-absorption
of water
Bloodstream Feces/Excretion
*SCFA = Short-Chain Fatty Acids (acetate, propionate, butyrate)
CH4
© 2016 BENEO
A complex orchestra that is positively influenced
by chicory root fibers
not digestible in small intestine
water binding capacity
softer stools
bacterial fermentation in large intestine
bacteria
bowel content
fecal bulk
intestinal transit time
bowel movement frequency
gas production
SCFA production
water content of digesta/feces
chemical stimulation of peristaltic reflex
9
Physiological mechanism fully
accepted by EFSA.
The prebiotic fermentation of chicory
inulin plays a key role!
© 2016 BENEO
Art. 13(5) EU dossier on inulin and normal bowel
function: human studies
10
0 20 40 60 80 100
Isakov et al (2013) - 3 g/d
Bouhnik et al (2007) - 5 g/d
Kolida et al (2007) - 5 g/d
Brighenti et al (1999) - 9 g/d
Schulz et al (2012) - 12 g/d
Grasten et al (2003) - 13 g/d
Den Hond et al (2000) - 15 g/d
Kleessen et al (2007) - 15 g/d
Gibson et al (1995) - 15 g/d
Kleessen et al (1997) - 20 g/d
Kleessen et al (1997) - 40 g/d
Stool frequency increase, chicory inulin vs. placebo/control (%)
*
*
Improvement
* Proprietary & confidential study
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on the substantiation of a health claim
related to “native chicory inulin” and maintenance of normal defecation by increasing stool frequency pursuant to Article 13(5) of Regulation (EC)
No 1924/2006. EFSA Journal 2015;13(1):3951, 12 pp. doi:10.2903/j.efsa.2015.395
© 2016 BENEO
Art. 13(5) - Orafti®inulin & normal bowel function
Commission Regulation (EU) 2015/2314
11 Ref. Commission Regulation (EU) 2015/2314 of 7 December 2015 authorising a health claim made on foods, other than those referring to the reduction of disease risk
and to children's development and health and amending Regulation (EU) No 432/2012; available at:
http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32015R2314&rid=1
© 2016 BENEO
Orafti®Inulin improves bowel function by more
frequent bowel movements
12
Randomised, PC, DB,cross-over design
Bowel movement frequency after a 4 week ingestion of 12 g/d (3x4 g)
Orafti®Inulin compared to maltodextrin
Consumption of 12 g/d
Orafti®Inulin led to a
significantly higher
frequency of bowel
movements compared
to maltodextrin
p = 0.038
*
0
1
2
3
4
5
Maltodextrin Orafti® Inulin
Bo
we
l m
ove
me
nts
/we
ek
Maltodextrin
Orafti® Inulin
Micka et al (2016) Int J Food Sci Nutr 5:1-8. [Epub ahead of print]
© 2016 BENEO
Gastrointestinal comfort
• Assessed with a GI symptoms diary (5-point scale):
• 0 = not at all, 1 = very slightly, 2 = slightly, 3 = moderately, 4 = extremely
• Straining • lower with inulin (“not at all”) vs. maltodextrin (“very slightly” to “not at all”)
• Feeling of incomplete emptying • Comparably low with median 1.0 for inulin and 1.3 for maltodextr. (“very slightly”)
• Abdominal discomfort • Similar in both periods rated as “not at all”
• Bloating/distension • No stat. signif. difference: 0.9 for maltodextrin and 1.1 for inulin (“very slightly”)
• Passage of gas • “very slightly” to “slightly” range (1.1-1.9)
Micka et al (2016) Int J Food Sci Nutr 5:1-8. [Epub ahead of print]
© 2016 BENEO
PAC-QOL - Health related QoL questionnaire
specific for constipated subjects
• PAC-QOL (Patient-Assessment of Constipation Quality of Life)
• a validated instrument to assess QoL in patients suffering from constipation.
• Selected validated test blocks: physical discomfort and satisfaction dimension
• The lower the score, the better rated is the quality of life
• Satisfaction improved during inulin vs. maltodextrin (p=0.059) intake
14 Micka et al (2016) Int J Food Sci Nutr 5:1-8. [Epub ahead of print]
© 2016 BENEO
Inulin in patients with gastrointestinal
hypersensitivity
Azpiroz et al. (2016) J Clin Gastroenterol [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/27680592 , accessed October 06, 2016. 15
Study design
• Placebo-controlled, parallel, randomized, double-blind study
• 36 Subjects with abdominal symptoms and reduced tolerance of intestinal gas
• Inulin (2 x 4 g/day, in liquid, at breakfast and dinner) vs maltodextrin (2 x 4 g/d)
• 4 weeks intervention
• Gas challenge test
© 2016 BENEO
Gas test: gas retention & perception
16
Significantly reduced gas retention
with inulin
p = 0.035
0
100
200
300
400
500
600
700
800
Baseline End Baseline End
Ga
s r
eta
ine
d (
ml)
Placebo Inulin
0
1
2
3
4
5
6
15 30 45 60 75 90 105 120 135 150 165 180
Pe
rce
pti
on
(s
co
re)
Time (min)
Placebo Baseline
Placebo End
Inulin Baseline
Inulin End
Azpiroz et al. (2016) J Clin Gastroenterol [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/27680592 , accessed October 06, 2016.
Both inulin and placebo significantly
reduced perception score to a similar extent
© 2016 BENEO
Results: gastrointestinal symptoms
17
0
2
4
6
8
10
Baseline End Baseline End
Sc
ore
Flatulence
Placebo Inulin
0
1
2
3
4
5
6
7
8
9
10
Baseline End Baseline End
Sc
ore
Borborygmi
Placebo Inulin
0
2
4
6
8
10
Baseline End Baseline End
Sc
ore
Discomfort/pain
Placebo Inulin
-5
-4
-3
-2
-1
0
1
2
3
4
5
Baseline End Baseline EndSc
ore
Digestive well-being
Placebo Inulin
0
2
4
6
8
10
Baseline End Baseline End
Sc
ore
Bloating
Placebo Inulin
CONCLUSION
GI symptoms are in the medium range (in both groups) as expected in hypersensitive
subjects, with no differences between groups
Results are in line with perception data during gas test: no GI stress with inulin
Azpiroz et al. (2016) J Clin Gastroenterol [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/27680592 , accessed October 06, 2016.
© 2016 BENEO
Conclusion from the publication
Azpiroz et al. (2016) J Clin Gastroenterol [Epub ahead of print].
https://www.ncbi.nlm.nih.gov/pubmed/27680592 , accessed October 06, 2016.
18
“In this context, our study indicates that a daily dose of inulin, which
promotes the proliferation of bifidobacteria, is well tolerated by
hypersensitive subjects with gastrointestinal complaints and may have
favourable effects on gut function. Hence, the current study would favor
the use of inulin over restrictive dietary advice such as FODMAPs
restriction to treat functional gastrointestinal symptoms, at least in
patients with normal bowel habits or constipation. “
Prof F. Azpiroz et al.
© 2016 BENEO
What are prebiotics?
“A dietary prebiotic is a selectively fermented ingredient that results in specific changes in the
composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon
host health.”
- International Scientific Association for Probiotics and Prebiotics (ISAPP), Nov 2008, London, Ontario -
Characteristics of prebiotics (Gibson et al., 2004):
• Resistance to hydrolysis and absorption
• Fermented by intestinal microflora
• Selective stimulation of growth and/or activity of intestinal bacteria ( bifidobacteria, lactobacilli)
associated with health and disease
Confirmed prebiotics (ISAPP 2008, Gibson et al., 2010) :
• Inulin-type Fructans
(Orafti® inulin, oligofructose, Synergy1)
• Galactans
• Lactulose
HO O
HO OH
OH
O HO
OH
O HO
O HO
OH
O
O HO
OH OH
O
n
inulin
oligofructose
© 2016 BENEO
Bifidobacteria increase: marker for prebiotic
benefits of chicory root fibers
0
2
4
6
8
10
12
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
10lo
g f
ae
ca
l b
ifid
ob
ac
teri
a c
ou
nts
pe
r m
l
Individual studies*
Significant bifidobacteria increase with inulin and/or oligofructose in adults
20
control/
baseline/
placebo
inulin/
oligofructose
*List of references is available upon request
© 2016 BENEO
Related health outcomes of chicory root fibers are
seen along two mechanistic routes...
21
Selective proliferation of beneficial bacteria,
mainly bifidobacteria and lactobacilli
Stimulation of beneficial microbial activities
Figure modified from Crittenden 2006; Source: Windows to Science 1/2012: Prof. RA Rastall: Healthy Human gut microbiota
– Specific perspectives. Presented at 2nd European BENEO Scientific Symposium, 12-13 March 2012,
© 2016 BENEO
Stable-isotope method
Figure: Eef Boets (KU Leuven), Gut day 2014, Posterpresentation
Boets et al (2015) Nutrients 7: 8916-8929 22
Production of SCFA
during bacterial
fermentation of inulin in
the colon
SCFA are transported
through the portal vein
into liver
Constant infusion with
labeled SCFA results in
enrichment of labeled SCFA
in plasma
Colonic fermentation whole- body
SCFA lowering labeled SCFA
enrichment and increased SCFA
turnover
Increase of SCFA
turnover represents the
part of SCFA produced in
the colon
© 2016 BENEO
Amounts and proportions produced in vivo after
consumption of inulin
23
Quantification of the colonic production of SCFA in healthy humans after
inulin intake using a stable-isotope dilution method.
Estimated colonic production within 12 h was:
• Acetate: 137 mmol (82%)
• Propionate: 11 mmol (6%)
• Butyrate: 20 mmol (12%)
Boets et al (2015) Nutrients 7: 8916-8929
Inulin is basically fermented to
acetate > butyrate > propionate
Results confirm earlier in vitro studies
Unique study using a stable-isotope diluation
method
© 2016 BENEO
24 Roberfroid et al, Br J Nutr 2010, 104 (Suppl 2)
Main physiological targets for prebiotic effects -
From immunity to weight management…
Increase in mineral absorption
and improvement of bone health
(bone Ca content, BMD)
Improvement of intestinal functions
(stool regularity, bulking, consistency)
Improvement and/or stabilization
of gut microbiota composition
Modulation of GI peptide
production, energy metabolism
and satiety
Reduction of risk of obesity,
T2DM, Metabolic Syndrome
Improvement of intestinal barrier functions,
reduction of metabolic endotoxemia
Reduction of risk of
intestinal infections
Initiation and modulation
of immune response
Health benefits and
main physiological
targets for
prebiotic effects
© 2016 BENEO
Additional outreach of prebiotic fermentation of
chicory root fibers
25
• Increase in calcium absorption to support bone strength • Change in true calcium absorption
at 8-week and at 1-year intervention1:
• Cholesterol-lowering effect • Inclusion criteria of meta-analysis2:
• Randomized control trial
• Mean TC, LDL-c, HDL-c, TG concentration
• Products enriched with inulin only
• Conclusion: Based on this meta-analysis, it can be stated that oral inulin has beneficial
effects on total cholesterol and LDL-c, as well as triglyceride concentration in the
plasma of hyperlipidemic subjects, and has no effects on plasma lipids in
normolipidemic subjects.
1 Abrams et al. (2005) Am J Clin Nutr 82(2):471-476. 2 Guo et al. (2012) Clin. Lipidol. 7(2):215-222.
* P < 0.001
** P = 0.04
© 2016 BENEO
Recent systematic reviews & meta-analyses for
prebiotics and inulin-type fructans
• Preventive use of prebiotics decreases the rate of
infections in infants and children (Lohner et al. 2014)
• Prebiotics consumption associated with
improvements in satiety and reductions in
postprandial glucose and insulin (Kellow et al. 2014)
• Inulin has beneficial effects on total cholesterol
and LDL-C as well as triglycerides in
hyperlipidemic subjects (Guo et al. 2012)
• Prebiotics reduce total cholesterol and LDL-C in
adult subjects with overweight and obesity;
Prebiotics reduce triglyceride and increase HDL-C
levels in diabetics (Beserra et al. 2014)
• Inulin-type fructans may have benefits for LDL-C
reduction (all study populations), improvements
shown for HDL-C and glucose control in
T2DM (Liu et al. 2016)
© 2016 BENEO
Subjective Appetite Ratings
Satiety Regulation (Hormones)
Energy Intake
Body Weight / Composition
I can
measure it
Satiety, energy intake & body weight
I can
sense it
It works:
It makes me eat
less!
It has an effect on
me and my body!
Chicory root
fibres reduce
the caloric
intake!
© 2016 BENEO
From the colon to other organs of the body: The
reach-out of the microbiota …
Brain
Lung breath
Kidney urine
Blood
Liver
Neurotransmitter
Serotonin Cytokines
Bacterial metabolites
SCFA, others
GLP-1, PYY,..
microbiota
Large
intestine
Immune cells Nervous system Hormonal system
28
© 2016 BENEO
Animal study with Orafti®Synergy1: Importance of acetate
derived from colonic fermentation for effects on appetite
• Orafti® Synergy1 results in reduced energy intake and lower body weight gain
• Peripheral acetate infusions reduce energy intake suggests acetate as an anorectic signal
• Acetate derived from colonic fermentation is taken up by the brain, preferentially accumulates in the hypothalamus and impacts hypothalamic metabolism Change in anorectic / orexigenic neuropeptide expression favoring reduction in appetite and body weight
• Neuronal activity pattern in the brain stimulated by acetate infusions is identical to that observed upon inulin feeding
Acetate might play central role for chicory root fiber effects on energy intake and body weight
29 Frost et al. (2014) Nature Commun5:3611.
© 2016 BENEO
Chicory root fibres reduce energy intake
8 g/d
Orafti®Synergy1
Orafti®P95
Other OF
Inulin
1)
*
*
**
*
*
*
**
1)
*
*
*
*
1) Data not reported in % energy intake change * p < 0.05 ** p < 0.01
Patterned bars represent supportive evidence from
self-reported data or discontinuous fibre intake.
Version: 11 Nov 2015
1
2
30
Consistent evidence from
several human
intervention studies for
normal weight, overweight
and obese adults and
children
© 2016 BENEO
Chicory root fibres
Supporting gut health and beyond…
Type of key studies Demonstrated physiological properties
Mouth Not fermented
Small Intestine Patients with ileostomy Not digested/absorbed
Glycemic response
Insulin response
When replacing sugars/available carbohydrates
When replacing sugars/available carbohydrates
Large Intestine Prebiotic Selective stimulation of mutualistic microbiota (bifidobacteria )
Fully fermentable Beneficial saccharolytic fermentation , proteolytic fermentation
-> Short chain fatty acids , pH
Bowel function Improved bowel motor function, stool frequency
Mineral absorption Calcium absorption
Bone mineral density
Gastrointestinal tolerance
Subjective perception of the increased gut activity might be
noticeable at high intakes, but generally not disturbing
Metabolism Weight management Energy intake
Weight , influence on satiety, fat mass
Inner resistance Incidence of infectious diseases
Attenuation of glycaemia /
insulinaemia – long term
Glycated haemoglobin (HbA1c) and fructosamine , insulin
resistance (HOMA)
Calorie Reduction / Fibre enrichment
Sugar or fat replacement
When replacing starch, sugar or fat calories (caloric value
2 kcal/g)
31
© 2016 BENEO
BENEO at Food Matters Live
32
Want to learn more? - Visit us:
Stand 200 - Innovation Lounge
The BENEO people are eager and honored to meet you!
© 2016 BENEO
Questions
33